Get the app!
Back to Trades
Grant4

ALLURION TECHNOLOGIES, INC.

ALUR

Total Value
$6.2M
Grants
$3.1M
3 transactions

Company Information

Ticker Symbol
ALUR
CIK
0001964979

Insider Information

Role
Insider
Location
NEW YORK, NY

Filing Details

Filing Date
Nov 13, 2025
Transaction Date
Nov 12, 2025
Accession Number
0001231919-25-000468
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Nov 12, 2025Common Stock, $0.0001 par value per share991,544$1.67Grant/Award$1.7M
Nov 12, 2025Common Stock, $0.0001 par value per share767,848$1.67Grant/Award$1.3M
Nov 12, 2025Common Stock, $0.0001 par value per share96,896$1.67Grant/Award$161.8K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Nov 12, 2025Derivative991,544$1.67Grant/Award$1.7M
Nov 12, 2025Derivative767,848$1.67Grant/Award$1.3M
Nov 12, 2025Derivative96,896$1.67Grant/Award$161.8K

Footnotes

  1. (F1)The Reporting Persons acquired the shares of Common Stock and Warrants in a private placement by the Issuer. The purchase price per share of Common Stock and accompanying Warrant was $1.67 per share and accompanying Warrant.
  2. (F2)RTW Investments, LP (the "Adviser") manages certain funds that directly hold the securities reported herein, including RTW Master Fund, Ltd. ("Master Fund"), RTW Innovation Master Fund, Ltd. ("RTW Innovation") and other funds or accounts managed by the Adviser (each, an "Other RTW Fund"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of the Adviser. Each Reporting Person disclaims beneficial ownership of the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  3. (F3)Held directly by Master Fund.
  4. (F4)Held directly by RTW Innovation.
  5. (F5)Held by an Other RTW Fund.
  6. (F6)The Warrant is exercisable following receipt of the Stockholder Approval (as defined herein) at an exercise price of $1.67 per share and terminates on the five year anniversary of the date of the Stockholder Approval. The holder of the Warrant may not exercise such Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. The Issuer is required to use its reasonable best efforts to hold a meeting of stockholders no later than January 31, 2026 for the purpose of, among other things, obtaining stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the Warrants (the "Stockholder Approval").

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.